Aromatase inhibitors in the treatment of advanced breast cancer.
Miller
W R
WR
University Department of Clinical Oncology, Western General Hospital, Edinburgh, U.K.
D000616:Aminoglutethimide / Q000627:therapeutic use; D000735:Androstenedione / Q000031:analogs & derivatives / Q000627:therapeutic use; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy*; D017316:Fadrozole; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D009570:Nitriles / Q000627:therapeutic use
D047072:Aromatase Inhibitors; D007093:Imidazoles; D009570:Nitriles; D000616:Aminoglutethimide; D000735:Androstenedione; D017316:Fadrozole; C014594:formestane